Evidence map›Paper›PMID 28127051›Full record

ArticleScientific reports2017

Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness.

Michiru Nishita, Seung-Yeol Park, Tadashi Nishio, Koki Kamizaki, ZhiChao Wang, Kota Tamada, Toru Takumi, Ryuju Hashimoto, Hiroki Otani, Gregory J Pazour and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed, 3 pooled it
599.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 3 syntheses or guidelines pooled it, 16,079 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Methods to Study Arginylation of Tubulin.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Michiru NishitaDivision of Cell Physiology, Department of Physiology and Cell Biology, Kobe University, Graduate School of Medicine, Kobe, 650-0017, Japan. nishita@med.kobe-u.ac.jp.
Seung-Yeol ParkDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.
Tadashi NishioDivision of Cell Physiology, Department of Physiology and Cell Biology, Kobe University, Graduate School of Medicine, Kobe, 650-0017, Japan.
Koki KamizakiDivision of Cell Physiology, Department of Physiology and Cell Biology, Kobe University, Graduate School of Medicine, Kobe, 650-0017, Japan.
ZhiChao WangDivision of Cell Physiology, Department of Physiology and Cell Biology, Kobe University, Graduate School of Medicine, Kobe, 650-0017, Japan.
Kota TamadaRIKEN Brain Science Institute, Wako, 351-0198, Japan.
Toru TakumiRIKEN Brain Science Institute, Wako, 351-0198, Japan.
Ryuju HashimotoDepartment of Developmental Biology, Faculty of Medicine, Shimane University, Izumo, 690-8504, Japan.
Hiroki OtaniDepartment of Developmental Biology, Faculty of Medicine, Shimane University, Izumo, 690-8504, Japan.
Gregory J PazourProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA.ORCID 0000-0002-6285-8796
Victor W HsuDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.
Yasuhiro MinamiDivision of Cell Physiology, Department of Physiology and Cell Biology, Kobe University, Graduate School of Medicine, Kobe, 650-0017, Japan. minami@kobe-u.ac.jp.
Kobe University · JPBrigham and Women's Hospital · USRIKEN Center for Brain Science · JPShimane University · JPUniversity of Massachusetts Chan Medical School · US

Funding

Intraflagellar Transport Proteins in MiceR01GM060992 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Gregory J Pazour · 2001 to 2026
$10.3M
Mechanisms and Physiology of COPI TransportR37GM058615 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI HSU, VICTOR W · 2016 to 2025
$6.0M
COPI TransportR01GM058615 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI HSU, VICTOR W · 2001 to 2015
$5.7M
NIGMS NIH HHS R01 GM058615NIGMS NIH HHS R01 GM060992NIGMS NIH HHS R37 GM058615
6 · The paper itself

Abstract

Signaling through the Ror2 receptor tyrosine kinase promotes invadopodia formation for tumor invasion. Here, we identify intraflagellar transport 20 (IFT20) as a new target of this signaling in tumors that lack primary cilia, and find that IFT20 mediates the ability of Ror2 signaling to induce the invasiveness of these tumors. We also find that IFT20 regulates the nucleation of Golgi-derived microtubules by affecting the GM130-AKAP450 complex, which promotes Golgi ribbon formation in achieving polarized secretion for cell migration and invasion. Furthermore, IFT20 promotes the efficiency of transport through the Golgi complex. These findings shed new insights into how Ror2 signaling promotes tumor invasiveness, and also advance the understanding of how Golgi structure and transport can be regulated.

Indexed as

Carrier ProteinsCell Line, TumorCell MovementGolgi ApparatusHumansMesenchymal Stem CellsMicrotubulesNeoplasm InvasivenessPodosomesReceptor Tyrosine Kinase-like Orphan ReceptorsRNA, Small InterferingSignal TransductionCarrier ProteinsIFT20 protein, humanReceptor Tyrosine Kinase-like Orphan ReceptorsRNA, Small Interfering

Identifiers

PMID28127051
PMCPMC5428335
OpenAlexW2580767461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.